Discover VELSIPITY®, a once-daily oral prescription medicine that treats moderately to severely active ulcerative colitis (UC) in adults. See risks & benefits.

Indication VELSIPITY ® (etrasimod) is indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults.

19 Lún 2024 · Velsipity (Vel-sip-itee) was approved in 2023 to treat moderate to severe ulcerative colitis in adults. How Does It Work?

13 DFómh 2023 · VELSIPITY is a proven advanced treatment with a favorable benefit-risk profile.” “UC can affect patients differently and many people living with this disease struggle with ongoing …

20 Meith 2024 · Velsipity (etrasimod) is a once-daily tablet used to treat ulcerative colitis that is moderate to severe in adults. Velsipity works to improve ulcerative colitis symptoms and to help …

Discover what VELSIPITY® (etrasimod) moderate to severe ulcerative colitis treatment can offer your adult patients. See safety info.

Learn about taking Rx treatment for moderate to severe UC VELSIPITY®, see resources, download a brochure to learn more, and see steps to take to get started.

24 DFómh 2023 · The FDA approved Velsipity (etrasimod), a drug by Pfizer to treat ulcerative colitis. The daily oral pill can reduce inflammation in the gut and help patients reach remission. The approval …

VELSIPITY™ (etrasimod) What is VELSIPITY? What is VELSIPITY? • VELSIPITY is a prescription medicine used to treat adults with moderately to severely active ulcerative colitis. It is not known if …

14 Noll 2023 · Velsipity (etrasimod) is a prescription oral tablet that treats ulcerative colitis in adults. Learn about this drug's cost, dosage, side effects, and more.